CID 56952080

Brezivaptan

Structural Information

Molecular Formula
C25H30ClN5O3
SMILES
CC(C)NC(=O)CN1C(=NN(C1=O)C2=CC=C(C=C2)CCN3CCOCC3)C4=CC(=CC=C4)Cl
InChI
InChI=1S/C25H30ClN5O3/c1-18(2)27-23(32)17-30-24(20-4-3-5-21(26)16-20)28-31(25(30)33)22-8-6-19(7-9-22)10-11-29-12-14-34-15-13-29/h3-9,16,18H,10-15,17H2,1-2H3,(H,27,32)
InChIKey
YCLGGNJZGIFVKX-UHFFFAOYSA-N
Compound name
2-[3-(3-chlorophenyl)-1-[4-(2-morpholin-4-ylethyl)phenyl]-5-oxo-1,2,4-triazol-4-yl]-N-propan-2-ylacetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

13
Patents

483.2037 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 484.21098 218.4
[M+Na]+ 506.19292 223.3
[M-H]- 482.19642 225.8
[M+NH4]+ 501.23752 220.6
[M+K]+ 522.16686 217.1
[M+H-H2O]+ 466.20096 205.1
[M+HCOO]- 528.20190 226.8
[M+CH3COO]- 542.21755 224.2
[M+Na-2H]- 504.17837 214.3
[M]+ 483.20315 220.0
[M]- 483.20425 220.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe